Jump to content

Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia (Q33444251)

From Wikidata
scientific article
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia
    scientific article

      Statements

      Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia (English)

      Identifiers

       
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      edit